Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

142.58
Delayed Data
As of May 05
 +1.17 / +0.83%
Today’s Change
124.16
Today|||52-Week Range
208.88
-25.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues600.3M604.6M637.1M700.9M
 
 
 
 
 
Cost of Goods Sold69.4M45.1M45.7M43.8M
 
 
 
 
 
Depreciation And Amortization10.6M12.6M49.7M93.8M
 
 
 
 
 
 
Operating ExpensesGross Income520.4M547.0M541.7M563.3M
 
 
 
 
 
General Expenses397.6M347.5M373.5M432.6M
 
 
 
 
 
Research And Development216.5M126.1M161.0M191.0M
 
 
 
 
 
Total Operating Expenses477.6M405.1M468.8M570.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income122.7M199.5M168.3M130.7M
 
 
 
 
 
Extraordinary Credit7.7M0.000.000.00
 
 
Extraordinary Charge-19.0M-50.0M-43.2M-33.3M
 
 
 
 
 
Interest Expense On Debt651.0K4.0M20.0M23.2M
 
 
 
 
 
Other Expenses-6.6M29.6M32.3M-1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income106.9M177.3M139.4M74.5M
 
 
 
 
 
Income Taxes-15.6M-7.1M-323.1M-7.9M
 
 
 
 
 
Net Income91.3M170.2M-183.8M66.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS199.4M202.2M226.2M225.5M
 
 
 
 
 
Shares To Calculate EPS Diluted202.0M204.5M226.2M228.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.45$0.83-$0.81$0.29
 
 
 
 
 
EPS Diluted$0.45$0.83-$0.81$0.29